(Q44421448)

2 December 2017

title

Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant (English)

1 reference

2 December 2017

2

Brenda M Sandmaier

1 reference

2 December 2017

6

Thomas R Chauncey

1 reference

2 December 2017

15

Rainer F Storb

1 reference

2 December 2017

3

David G Maloney

1 reference

2 December 2017

7

Ute Hegenbart

1 reference

2 December 2017

Lyle C. Feinstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720219

28 December 2023

Michael B. Maris

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720219

28 December 2023

Theodore A. Gooley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720219

28 December 2023

Peter A. McSweeney

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720219

28 December 2023

Monic J. Stuart

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720219

28 December 2023

Stephen J. Forman

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720219

28 December 2023

Edward A. Agura

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720219

28 December 2023

Michael A. Pulsipher

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720219

28 December 2023

Karl G. Blume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720219

28 December 2023

Dietger W. Niederwieser

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720219

28 December 2023

Rainer F. Storb

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720219

28 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12720219

28 December 2023

publication date

1 April 2003

1 reference

full work available at URL

2 December 2017

https://doi.org/10.1053/bbmt.2003.50014

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720219

https://api.elsevier.com/content/article/PII:S108387910300003X?httpAccept=text/xml

28 December 2023

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

https://api.elsevier.com/content/article/PII:S108387910300003X?httpAccept=text/plain

28 December 2023

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Biology of Blood and Marrow Transplantation

28 December 2023

published in

1 reference

2 December 2017

volume

9

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

266-272

1 reference

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

2 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Second allogeneic transplantation after failure of first autologous transplantation

28 December 2023

3

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma

28 December 2023

4

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

28 December 2023

5

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?

28 December 2023

6

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation.

28 December 2023

7

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

28 December 2023

8

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation

28 December 2023

9

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

28 December 2023

11

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma

28 December 2023

13

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

28 December 2023

15

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation

28 December 2023

16

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

28 December 2023

18

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

28 December 2023

19

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

28 December 2023

22

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

28 December 2023

27

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

28 December 2023

28

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Acyclovir prophylaxis of herpes-simplex-virus infections

28 December 2023

29

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

28 December 2023

30

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation

28 December 2023

32

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.

28 December 2023

33

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant

28 December 2023

34

1 reference

https://api.crossref.org/works/10.1053/BBMT.2003.50014

28 December 2023

Identifiers

1 reference

2 December 2017

1 reference